Shanghai Haohai Biological Technology Co (SHSE:688366) Research & Development: ¥151 Mil (TTM As of Mar. 2026)


SHSE:688366 Shanghai Haohai Biological Technology Co Ltd SHSE:688366
69 GF Score
Price ¥28.61
GF Value ¥43.53
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Haohai Biological Technology Co Research & Development?

Shanghai Haohai Biological Technology Co SHSE:688366 -3.57% 69 Research & Development is ¥151 Mil as of Mar. 2026. GuruFocus rates SHSE:688366 with a GF Score™ of 69/100 and a GF Value™ of ¥43.53 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Shanghai Haohai Biological Technology Co's Research & Development for the three months ended in Mar. 2026 was ¥52 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥151 Mil.

Shanghai Haohai Biological Technology Co  (SHSE:688366) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Shanghai Haohai Biological Technology Co Research & Development Related Terms

Shanghai Haohai Biological Technology Co Research & Development Historical Data

* Premium members only.

The historical data trend for Shanghai Haohai Biological Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haohai Biological Technology Co Research & Development Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 167.60 182.19 220.10 238.93 197.78

Shanghai Haohai Biological Technology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.79 0.00 50.70 48.68 51.99
SHSE:688366
69GF Score
Shanghai Haohai Biological Technology Co Ltd SHSE:688366
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Haohai Biological Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥151 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥151 Mil mean?
Shanghai Haohai Biological Technology Co (SHSE:688366) has a Research & Development of ¥151 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Shanghai Haohai Biological Technology Co and its competitors.
Is Shanghai Haohai Biological Technology Co's Research & Development too high?
Shanghai Haohai Biological Technology Co's current Research & Development is ¥151 Mil. Overall, Shanghai Haohai Biological Technology Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haohai Biological Technology Co's Research & Development compare to VRTX and REGN?
Shanghai Haohai Biological Technology Co's Research & Development of ¥151 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Shanghai Haohai Biological Technology Co and its competitors. Shanghai Haohai Biological Technology Co's current Research & Development is ¥151 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haohai Biological Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co (SHSE:688366) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥43.53, compared to a current price of ¥28.61 — trading 34.3% below its estimated fair value. The current Research & Development is ¥151 Mil. Shanghai Haohai Biological Technology Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Shanghai Haohai Biological Technology Co (SHSE:688366), the current Research & Development is ¥151 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Haohai Biological Technology Co (SHSE:688366) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co stock appears to be undervalued. The current stock price of ¥28.61 is trading 34.3% below its estimated GF Value™ of ¥43.53. GuruFocus considers Shanghai Haohai Biological Technology Co to be Significantly Undervalued.

Key valuation signals for SHSE:688366:

  • Research & Development: ¥151 Mil
  • GF Value™: ¥43.53 vs. price of ¥28.61 (34.3% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688366 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Haohai Biological Technology Co Business Description

Other Exchanges 06826:Hong Kong5HB:Germany
Address No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
69GF Score

Get the complete analysis for SHSE:688366

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.61
Price
¥43.53
GF Value